Project Architecture & Scientific Overview

This project, conducted within the Keyora Neuro–Psycho–Sleep Framework, investigates a multi-nutrient, evidence-based neuro-nutrition strategy.

The research focuses on the "Tri-Axis Regulation" of the brain to alleviate depression, reduce anxiety, improve sleep quality, and maintain cognitive performance in individuals experiencing high mental workload or chronic stress.

The intervention is defined by its systemic integration of eight synergistic bioactive compounds that target both acute clinical symptoms and the underlying neurophysiological imbalances.

---

II. Target Populations & Clinical Rationale

The research identifies and addresses the specific neuro-metabolic needs of six primary cohorts characterized by heightened stress vulnerability:

1. Depressive Tendencies:

Individuals presenting with persistent low mood, loss of motivation (anhedonia), and morning symptom worsening.

2. Anxiety States:

Those suffering from excessive worry, inner tension, sympathetic over-activation (e.g., rapid heart rate), and heightened stress reactivity.

3. Insomnia & Circadian Disruption:

Focus on "Anxious Insomnia," characterized by difficulty falling asleep (latency), fragmented sleep, and early morning awakenings.

4. High Cognitive Workload:

Knowledge workers, students, and researchers facing "thought overflow," mental drift, and reduced processing speed.

5. Professional Chronic Stress:

High-responsibility roles (executives, healthcare providers) experiencing prolonged HPA axis activation and occupational burnout.

Menopausal Transition:

Addressing the neuro-endocrine-circadian triad dysfunction (brain fog, emotional lability) driven by ovarian decline and estrogen fluctuation.

---

The Tri-Axis Regulatory Mechanism

The core of the Keyora intervention is built upon three distinct but interconnected physiological axes:

Axis 1: Neurotransmitter Modulation (The Chemical Foundation)

- Serotonergic Enhancement:

Utilizing 5-HTP as a direct precursor to bypass the competitive transport bottleneck of tryptophan at the blood-brain barrier.

This is supported by Vitamin B6 (a required cofactor for AADC) and Vitamin D3 (which upregulates TPH2 expression) to maximize central 5-HT synthesis.

- GABAergic Stabilization:

Leveraging Magnesium Glycinate and L-Theanine to enhance inhibitory signaling.

Magnesium acts as a voltage-dependent blocker of NMDA receptors to reduce glutamate-induced excitotoxicity.

Axis 2: HPA Stress-Axis Regulation (The Endocrine Buffer)

Cortisol Balancing:

Standardized Ashwagandha root extract modulates the CRH-ACTH-Cortisol pathway, clinically shown to reduce salivary cortisol by up to 27.9%.

Resilience Building:

By dampening physiological arousal and sympathetic tone, the strategy prevents the "low-magnesium-high-cortisol" feedback loop that exacerbates chronic stress.

Axis 3: Circadian Rhythm Alignment (The Temporal Regulator)

Sleep–Wake Optimization:

Coordinating the transition from daytime mood stability (Serotonin) to nighttime sleep repair (Melatonin).

Rhythm Reconstruction:

Using Vitamin D to modulate the expression of circadian clock genes (Clock, BMAL) in the Suprachiasmatic Nucleus (SCN) and Ashwagandha to suppress nocturnal cortisol spikes that cause fragmented sleep.

---

Intended Therapeutic Outcomes

The multi-pathway model is designed to deliver five categorical benefits:

Mood Stabilization:

Achieved through high-efficiency serotonin synthesis and enhanced prefrontal cortex emotional control.

Anxiety Reduction:

Lowering the neural excitation threshold and suppressing hyper-reactivity of the amygdala.

Sleep Improvement:

Significant gains in sleep latency, restorative depth, and the reduction of vivid, stress-related dreaming.

Cognitive Resilience:

Inducing a "relaxed alertness" via Alpha-Wave enhancement (8-13 Hz) to sustain attention and working memory under load.

Stress Adaptation:

Upregulating BDNF (Brain-Derived Neurotrophic Factor) to support neuroplasticity and synaptic remodeling.

---

Mechanistic Intervention Protocols

The research implements a "closed-loop" nutritional approach:

1. Precursor Priming:

Direct 5-HTP supplementation to bypass the IDO-inflammatory shunt that otherwise diverts tryptophan toward neurotoxic metabolites.

2. Neuroinhibitory Support:

Providing dual-action Magnesium and Glycine to induce neuronal hyperpolarization and muscle relaxation.

3. Neuro-Energetic Support:

Integrating Vitamin B1 (Thiamine) to maintain neuronal mitochondrial energy metabolism and prevent "brain energy deficits".

4. Structural Protection:

Utilizing Vitamin B12 to maintain myelin sheath integrity and stable axonal signal conduction.

---

Data Strategy & Dissemination

The Keyora project is committed to open-science principles and will progressively share:

Detailed Rationale:

Full documentation on nutrient-to-pathway mapping and precision dosing.

Evidence Synthesis:

A living library of clinical evidence summaries (Level A and B) for all eight bio-actives.

Real-World Outcomes:

Aggregated, anonymized data reflecting the efficacy of the MoodFlow matrix across different target populations.

Iterative Evolution:

Regular updates to protocols based on emerging findings in the fields of nutritional psychiatry and neuro-endocrinology.